Prevalence of post-traumatic stress disorder symptoms in adult critical care survivors: a systematic review and meta-analysis

BackgroundAs more patients are surviving intensive care, mental health concerns in survivors have become a research priority. Among these, post-traumatic stress disorder (PTSD) can have an important impact on the quality of life of critical care survivors. However, data on its burden are conflicting. Therefore, this systematic review and meta-analysis aimed to evaluate the prevalence of PTSD symptoms in adult critical care patients after intensive care unit (ICU) discharge.MethodsWe searched MEDLINE, EMBASE, LILACS, Web of Science, PsycNET, and Scopus databases from inception to September 2018. We included observational studies assessing the prevalence of PTSD symptoms in adult critical care survivors. Two reviewers independently screened studies and extracted data. Studies were meta-analyzed using a random-effects model to estimate PTSD symptom prevalence at different time points, also estimating confidence and prediction intervals. Subgroup and meta-regression analyses were performed to explore heterogeneity. Risk of bias was assessed using the Joanna Briggs Institute tool and the GRADE approach.ResultsOf 13,267 studies retrieved, 48 were included in this review. Overall prevalence of PTSD symptoms was 19.83% (95% confidence interval [CI], 16.72-23.13; I-2=90%, low quality of evidence). Prevalence varied widely across studies, with a wide range of expected prevalence (from 3.70 to 43.73% in 95% of settings). Point prevalence estimates were 15.93% (95% CI, 11.15-21.35; I-2=90%; 17 studies), 16.80% (95% CI, 13.74-20.09; I-2=66%; 13 studies), 18.96% (95% CI, 14.28-24.12; I-2=92%; 13 studies), and 20.21% (95% CI, 13.79-27.44; I-2=58%; 7 studies) at 3, 6, 12, and >12months after discharge, respectively.ConclusionPTSD symptoms may affect 1 in every 5 adult critical care survivors, with a high expected prevalence 12months after discharge. ICU survivors should be screened for PTSD symptoms and cared for accordingly, given the potential negative impact of PTSD on quality of life. In addition, action should be taken to further explore the causal relationship between ICU stay and PTSD, as well as to propose early measures to prevent PTSD in this population.Trial registrationPROSPERO, CRD42017075124, Registered 6 December 2017.